Clinical trials of new biologics in patients with inflammatory bowel disease (IBD), such as upadacitinib (Rinvoq), have shown promising results, with remission rates ...

Infectious colitis is an inflammatory condition caused by bacteria, a virus, or a parasite. It can cause diarrhea and other symptoms. Treatment will depend on the cause. Infectious colitis causes ...

Upadacitinib (UPA; Rinvoq) is an oral selective inhibitor for Janus kinase 1 approved for the treatment of tumor necrosis factor (TNF)-alpha-experienced patients with inflammatory bowel disease (IBD).